Ito and colleagues reported lower IGF2 DMR0 methylation levels in 13 of 22 mammary tumor samples compared with histologically normal breast tissue from the same patient, with 7 tumor samples displaying less than 35% methylation [15]. Here, IGF2 is linked to neoplasm.